29.58
-0.08
(-0.27%)
At close: April 16 at 4:00:02 PM EDT
30.07
+0.49
+(1.66%)
Pre-Market: 6:25:41 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BEDROSIAN CAMILLE L Director | Stock Award(Grant) | Jun 7, 2024 | 9,400 |
| BETZ STEPHEN F Officer | Sale | Mar 19, 2025 | 108,588 |
| HASSARD JAMES Officer | Sale | Jul 5, 2024 | 29,259 |
| KNIGHT JEFF E Chief Operating Officer | Sale | Mar 19, 2025 | 87,491 |
| PIZZUTI DANA J Officer | Sale | Mar 19, 2025 | 72,233 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) | Mar 10, 2025 | 52,000 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Conversion of Exercise of derivative security | Apr 2, 2025 | 1,302,220 |
| VIVALDI COELHO ROGERIO Director | Stock Award(Grant) | Jun 7, 2024 | 14,400 |
| WIERENGA WENDELL Director | Stock Award(Grant) | Jun 7, 2024 | 109,246 |
| WILSON MARC Chief Financial Officer | Sale | Sep 26, 2024 | 111,092 |
Related Tickers
SRRK Scholar Rock Holding Corporation
29.76
-1.52%
MRUS Merus N.V.
41.91
-3.03%
BPMC Blueprint Medicines Corporation
82.11
+0.81%
NUVL Nuvalent, Inc.
69.97
-1.14%
PTGX Protagonist Therapeutics, Inc.
45.80
-2.45%
SWTX SpringWorks Therapeutics, Inc.
37.74
+0.40%
REPL Replimune Group, Inc.
7.63
-1.04%
RVMD Revolution Medicines, Inc.
36.20
-0.33%
SYRE Spyre Therapeutics, Inc.
12.42
-2.28%
ASND Ascendis Pharma A/S
158.15
+2.75%